Literature DB >> 68930

Transfer of delayed hypersensitivity in mice to microbial antigens with dialyzable transfer factor.

D Rifkind, J A Frey, E A Petersen, M Dinowitz.   

Abstract

Dialyzable Lawrence-type transfer factor was prepared from the spleen cells of CF1 mice inoculated with Coccidioides immitis- and Candida albicans-killed vaccines and with live Mycobacterium tuberculosis vaccine (BCG). These preparations were shown to transfer antigen-specific cell-mediated immunity to naive mice, as measured by the delayed skin test and footpad-swelling methods. Reactivity could be demonstrated when the test antigens were given 24 h after the transfer factor, but not when they were given simultaneously. Coccidioides-specific transfer factor was shown to be sensitive to Pronase and resistant to trypsin and ribonuclease. A preparation of BCG transfer factor was sensitive to snake venom phosphodiesterase.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 68930      PMCID: PMC421516          DOI: 10.1128/iai.16.1.258-262.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes.

Authors:  H S LAWRENCE
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

Review 2.  Transfer factor.

Authors:  H S Lawrence
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

3.  Delayed hypersensitivity to fungal antigens in mice. I. Use of the intradermal skin and footpad swelling tests as assays of active and passive sensitization.

Authors:  D Rifkind; J A Frey; J R Davis; E A Petersen; M Dinowitz
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

4.  Delayed hypersensitivity in the mouse.

Authors:  A J Crowle
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

5.  Delayed hypersensitivity to fungal antigens in mice. II. Characterization of the active component in immunogenic RNA extracts.

Authors:  D Rifkind; J A Frey; E A Petersen; M Dinowitz
Journal:  J Infect Dis       Date:  1976-05       Impact factor: 5.226

  5 in total
  6 in total

Review 1.  Transfer factor and other T cell products.

Authors:  K Y Tsang; H H Fudenberg
Journal:  Springer Semin Immunopathol       Date:  1986

2.  The effect of transfer factor on lymph node morphology in murine toxoplasmosis.

Authors:  S A Dundas; A Clark
Journal:  Br J Exp Pathol       Date:  1986-04

3.  Transfer of Salmonella resistance and delayed hypersensitivity with murine-derived transfer factor.

Authors:  R A Smith; A Esa; M Stiff
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

4.  Transfer factor: a murine model.

Authors:  M E Williams; C A Kauffman
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

5.  In vitro effect of murine-derived transfer factor on Salmonella-specific rosette formation.

Authors:  R A Smith; A Esa
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

6.  Susceptibility of murine transfer factor to dimerized ribonuclease A.

Authors:  D Rifkind; J A Frey; M Dinowitz
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.